Inventor
NIU DEQIANG
US82 patents
⚠️ This page may combine multiple inventors who share the name “NIU DEQIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE AVILOMICS RES INC
13 patentsUS8609679B2Dec 17, 2013
2,4-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC84 citations99
US9212181B2Dec 15, 2015
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC34 citations98
US9561228B2Feb 7, 2017
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC37 citations97
US8710222B2Apr 29, 2014
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC52 citations97
US9409921B2Aug 9, 2016
2,4-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC25 citations94
US9296737B2Mar 29, 2016
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC27 citations94
US9409887B2Aug 9, 2016
Mutant-selective EGFR inhibitors and uses thereof
CELGENE AVILOMICS RES INC16 citations92
US9375431B2Jun 28, 2016
2,4-disubstituted pyrimidine compounds useful as kinase inhibtors
CELGENE AVILOMICS RES INC21 citations92
US9321786B2Apr 26, 2016
Heteroaryl compounds and uses thereof
CELGENE AVILOMICS RES INC15 citations92
US9145387B2Sep 29, 2015
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC21 citations92
US9458175B2Oct 4, 2016
MK2 inhibitors and uses thereof
CELGENE AVILOMICS RES INC16 citations91
US9504686B2Nov 29, 2016
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC10 citations84
US8980935B2Mar 17, 2015
HCV protease inhibitors and uses thereof
CELGENE AVILOMICS RES INC7 citations84
CELGENE CAR LLC
13 patentsUS9987276B2Jun 5, 2018
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE CAR LLC23 citations94
US10010548B2Jul 3, 2018
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC15 citations92
US9867824B2Jan 16, 2018
Heterocyclic compounds and uses thereof
CELGENE CAR LLC11 citations92
US10577380B2Mar 3, 2020
MK2 inhibitors and uses thereof
CELGENE CAR LLC10 citations91
US10253040B1Apr 9, 2019
MK2 inhibitors and uses thereof
CELGENE CAR LLC12 citations91
US9790235B2Oct 17, 2017
MK2 inhibitors and uses thereof
CELGENE CAR LLC12 citations91
US10596172B2Mar 24, 2020
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC5 citations84
US10138256B2Nov 27, 2018
MK2 inhibitors and uses thereof
CELGENE CAR LLC11 citations84
US10081606B2Sep 25, 2018
Heteroaryl compounds and uses thereof
CELGENE CAR LLC8 citations84
US9980964B2May 29, 2018
ERK inhibitors and uses thereof
CELGENE CAR LLC11 citations84
US9796700B2Oct 24, 2017
ERK inhibitors and uses thereof
CELGENE CAR LLC7 citations84
US9765038B2Sep 19, 2017
Heteroaryl compounds and uses thereof
CELGENE CAR LLC11 citations84
US10434101B2Oct 8, 2019
Heterocyclic compounds and uses thereof
CELGENE CAR LLC4 citations83
ENANTA PHARM INC
12 patentsUS7635683B2Dec 22, 2009
Quinoxalinyl tripeptide hepatitis C virus inhibitors
ENANTA PHARM INC75 citations98
US6878691B2Apr 12, 2005
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC73 citations97
US7582605B2Sep 1, 2009
Phosphorus-containing hepatitis C serine protease inhibitors
ENANTA PHARM INC59 citations94
US7687459B2Mar 30, 2010
Arylalkoxyl hepatitis C virus protease inhibitors
ENANTA PHARM INC26 citations93
US7189704B2Mar 13, 2007
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC15 citations93
US7605126B2Oct 20, 2009
Acylaminoheteroaryl hepatitis C virus protease inhibitors
ENANTA PHARM INC38 citations92
US7273853B2Sep 25, 2007
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC35 citations92
US7129221B2Oct 31, 2006
6,11-bicyclic erythromycin derivatives
ENANTA PHARM INC25 citations92
US7662779B2Feb 16, 2010
Triazolyl macrocyclic hepatitis C serine protease inhibitors
ENANTA PHARM INC14 citations84
US7402568B2Jul 22, 2008
Bicyclic 9a-azalide derivatives
ENANTA PHARM INC16 citations84
US7265094B2Sep 4, 2007
9N-substituted 6-11 bicyclic erythromycin derivatives
ENANTA PHARM INC11 citations84
US7049417B2May 23, 2006
6,11-4-Carbon bridged ketolides
ENANTA PHARM INC12 citations84
NIU DEQIANG
5 patentsUS8778877B2Jul 15, 2014
HCV protease inhibitors and uses thereof
NIU DEQIANG10 citations84
US8741837B2Jun 3, 2014
HCV protease inhibitors and uses thereof
NIU DEQIANG10 citations84
US8524760B2Sep 3, 2013
HCV protease inhibitors and uses thereof
NIU DEQIANG9 citations84
US8293705B2Oct 23, 2012
HCV protease inhibitors and uses thereof
NIU DEQIANG12 citations84
US8188137B2May 29, 2012
HCV protease inhibitors and uses thereof
NIU DEQIANG13 citations84
LEE KWANGHO
3 patentsSINGH JUSWINDER
2 patentsPETTER RUSSELL C
1 patentSUN YING
1 patentShowing the top 50 of 82 patents by PatentIndex Score.